Healthy high growth potential
Results
5
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CDR | zł234.60 | 1.3% | -12.2% | zł23.4b | zł235.13 | 45.4 | 29.7% | 0.4% | Media | ||
ARH | zł53.80 | -1.8% | 15.7% | zł3.1b | zł55.15 | 15.9 | 24.4% | 3.3% | Consumer Durables | ||
LKD | zł23.50 | -1.3% | 7.3% | zł423.0m | zł16.77 | 72.7 | 53.0% | 2.1% | Real Estate Management and Development | ||
VRC | zł124.40 | -1.3% | 2.8% | zł2.7b | zł142.22 | 30.0 | 23.1% | 2.2% | Software | ||
CTX | zł74.90 | -0.8% | 81.8% | zł475.9m | zł86.83 | 199.8 | 112.6% | n/a | Pharmaceuticals & Biotech |
Page 1 of 1